P53 Activity Dominates That of P73 Upon Mdm4 Loss in Development and Tumorigenesis

Overview

Journal Mol Cancer Res

Specialty Cell Biology

Date 2015 Nov 4

PMID 26527653

Citations 6

Authors

Mehrnoosh Tashakori

Yun Zhang

Shunbin Xiong

M James You

Guillermina Lozano

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Mdm4 negatively regulates the p53 tumor suppressor. Mdm4 loss in mice leads to an embryonic lethal phenotype that is p53-dependent. Biochemical studies indicate that Mdm4 also binds p73, a member of the p53 family, with higher affinity than p53. In this study, the significance of the Mdm4 and p73 interaction in vivo during embryogenesis and tumorigenesis was examined. The data revealed that p73 loss did not rescue either the early Mdm4-deficient embryonic lethality or the runted phenotype of Mdm4(Δ2/Δ2) p53(+/-) embryos. Furthermore, studies in the developing central nervous system wherein both genes have prominent roles indicated that loss of p73 also did not rescue the Mdm4-null brain phenotype as did p53 loss. This p53 dependency occurred despite evidence for p73-specific transcriptional activity. In tumor studies, the combination of Mdm4 overexpression and p73 loss did not alter survival of mice or the tumor spectrum as compared with Mdm4 overexpression alone. In summary, these data demonstrate that the Mdm4-p73 axis cannot override the dominant role of p53 in development and tumorigenesis.

Implications: Genetic characterization of the Mdm4 and p73 interaction during development and tumorigenesis suggests new insight into the role of p53 family members, which may influence treatment options for patients.

Citing Articles

Structural diversity of p63 and p73 isoforms.

Osterburg C, Dotsch V Cell Death Differ. 2022; 29(5):921-937.

PMID: 35314772 PMC: 9091270. DOI: 10.1038/s41418-022-00975-4.

The long and the short of it: the MDM4 tail so far.

Haupt S, Mejia-Hernandez J, Vijayakumaran R, Keam S, Haupt Y J Mol Cell Biol. 2019; 11(3):231-244.

PMID: 30689920 PMC: 6478121. DOI: 10.1093/jmcb/mjz007.

TAp73 regulates ATP7A: possible implications for ageing-related diseases.

Lopriore P, Capitanio N, Panatta E, Di Daniele N, Gambacurta A, Melino G Aging (Albany NY). 2018; 10(12):3745-3760.

PMID: 30530920 PMC: 6326685. DOI: 10.18632/aging.101669.

Anatomy of Mdm2 and Mdm4 in evolution.

Tan B, Liew H, Chua J, Ghadessy F, Sing Tan Y, Lane D J Mol Cell Biol. 2017; 9(1):3-15.

PMID: 28077607 PMC: 6372010. DOI: 10.1093/jmcb/mjx002.

p53 pathway is involved in cell competition during mouse embryogenesis.

Zhang G, Xie Y, Zhou Y, Xiang C, Chen L, Zhang C Proc Natl Acad Sci U S A. 2017; 114(3):498-503.

PMID: 28049824 PMC: 5255589. DOI: 10.1073/pnas.1617414114.

References

Venkatachalam S, Shi Y, Jones S, Vogel H, Bradley A, Pinkel D . Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J. 1998; 17(16):4657-67. PMC: 1170795. DOI: 10.1093/emboj/17.16.4657. View

Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T . Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas. Med Pediatr Oncol. 2001; 36(1):42-4. DOI: 10.1002/1096-911X(20010101)36:1<42::AID-MPO1011>3.0.CO;2-K. View

Cheok C, Verma C, Baselga J, Lane D . Translating p53 into the clinic. Nat Rev Clin Oncol. 2010; 8(1):25-37. DOI: 10.1038/nrclinonc.2010.174. View

Xiong S, Van Pelt C, Elizondo-Fraire A, Liu G, Lozano G . Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development. Proc Natl Acad Sci U S A. 2006; 103(9):3226-31. PMC: 1413885. DOI: 10.1073/pnas.0508500103. View

Berg R, Aleck K, Kaplan A . Familial porencephaly. Arch Neurol. 1983; 40(9):567-9. DOI: 10.1001/archneur.1983.04050080067013. View

Gould D, Phalan F, Breedveld G, van Mil S, Smith R, Schimenti J . Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science. 2005; 308(5725):1167-71. DOI: 10.1126/science.1109418. View

Zeng X, Chen L, Jost C, Maya R, Keller D, Wang X . MDM2 suppresses p73 function without promoting p73 degradation. Mol Cell Biol. 1999; 19(5):3257-66. PMC: 84120. DOI: 10.1128/MCB.19.5.3257. View

Melino G, De Laurenzi V, Vousden K . p73: Friend or foe in tumorigenesis. Nat Rev Cancer. 2002; 2(8):605-15. DOI: 10.1038/nrc861. View

Dobbelstein M, Wienzek S, Konig C, Roth J . Inactivation of the p53-homologue p73 by the mdm2-oncoprotein. Oncogene. 1999; 18(12):2101-6. DOI: 10.1038/sj.onc.1202512. View

10.

Flores E, Tsai K, Crowley D, Sengupta S, Yang A, McKeon F . p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature. 2002; 416(6880):560-4. DOI: 10.1038/416560a. View

11.

Corn P, Kuerbitz S, van Noesel M, Esteller M, Compitello N, Baylin S . Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. Cancer Res. 1999; 59(14):3352-6. View

12.

Gembarska A, Luciani F, Fedele C, Russell E, Dewaele M, Villar S . MDM4 is a key therapeutic target in cutaneous melanoma. Nat Med. 2012; 18(8):1239-47. PMC: 3744207. DOI: 10.1038/nm.2863. View

13.

Li L, Tan Y, Chen X, Xu Z, Yang S, Ren F . MDM4 overexpressed in acute myeloid leukemia patients with complex karyotype and wild-type TP53. PLoS One. 2014; 9(11):e113088. PMC: 4236138. DOI: 10.1371/journal.pone.0113088. View

14.

Furutachi S, Matsumoto A, Nakayama K, Gotoh Y . p57 controls adult neural stem cell quiescence and modulates the pace of lifelong neurogenesis. EMBO J. 2013; 32(7):970-81. PMC: 3616292. DOI: 10.1038/emboj.2013.50. View

15.

Laurie N, Donovan S, Shih C, Zhang J, Mills N, Fuller C . Inactivation of the p53 pathway in retinoblastoma. Nature. 2006; 444(7115):61-6. DOI: 10.1038/nature05194. View

16.

Marine J, Francoz S, Maetens M, Wahl G, Toledo F, Lozano G . Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ. 2006; 13(6):927-34. DOI: 10.1038/sj.cdd.4401912. View

17.

Martinez-Delgado B, Melendez B, Cuadros M, Garcia M, Nomdedeu J, Rivas C . Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas. Int J Cancer. 2002; 102(1):15-9. DOI: 10.1002/ijc.10618. View

18.

Ho S, Kuzniecky R, Gilliam F, Faught E, Bebin M, Morawetz R . Congenital porencephaly: MR features and relationship to hippocampal sclerosis. AJNR Am J Neuroradiol. 1998; 19(1):135-41. PMC: 8337343. View

19.

Jacks T, Remington L, Williams B, Schmitt E, Halachmi S, Bronson R . Tumor spectrum analysis in p53-mutant mice. Curr Biol. 1994; 4(1):1-7. DOI: 10.1016/s0960-9822(00)00002-6. View

20.

Ihrie R, Reczek E, Horner J, Khachatrian L, Sage J, Jacks T . Perp is a mediator of p53-dependent apoptosis in diverse cell types. Curr Biol. 2003; 13(22):1985-90. DOI: 10.1016/j.cub.2003.10.055. View